{
    "clinical_study": {
        "@rank": "146115", 
        "arm_group": [
            {
                "arm_group_label": "A", 
                "arm_group_type": "Experimental", 
                "description": "Sarpogrelate versus placebo"
            }, 
            {
                "arm_group_label": "B", 
                "arm_group_type": "Experimental", 
                "description": "Atorvastatin 80mg versus no statin or simvastatin 20 mg if LDL > 130 mg/dl"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study was to to evaluate the effect of sarpogrelate, a selective serotonin\n      receptor antagonist, and high dose statin on the reduction of coronary spasm in the patients\n      with variant angina."
        }, 
        "brief_title": "The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Variant Angina", 
        "condition_browse": {
            "mesh_term": [
                "Angina Pectoris", 
                "Angina Pectoris, Variant", 
                "Coronary Vasospasm"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical history of chest pain compatible with variant angina; morning chest pain\n             aggravated by cold exposure.\n\n          -  Angiographically proven coronary spasm; TIMI flow < 3 by spontaneous coronary spasm\n             or intracoronary ergonovine spasm provocation test.\n\n        Exclusion Criteria:\n\n          -  Cardiac arrest by coronary spasm\n\n          -  Left main coronary spasm\n\n          -  Significant fixed coronary artery stenosis; Diameter stenosis > 70% in the major\n             epicardial artery by coronary angiography\n\n          -  Left ventricular ejection fraction < 30%\n\n          -  Coagulation disorders or bleeding tendency (Platelet count < 50k, PT INR > 2.0)\n\n          -  Significant liver disease (AST or ALT > 100 U/ml)\n\n          -  Renal failure (S-Cr > 2.0 mg/dl)\n\n          -  hypersensitivity for statin\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01674686", 
            "org_study_id": "2011-12-069"
        }, 
        "intervention": [
            {
                "arm_group_label": "A", 
                "description": "Sarpogrelate 100mg twice a day", 
                "intervention_name": "Sarpogrelate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "B", 
                "description": "Atorvastatin 80mg daily", 
                "intervention_name": "Atorvastatin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Serotonin Antagonists", 
                "Sarpogrelate", 
                "Atorvastatin", 
                "Hydroxymethylglutaryl-CoA Reductase Inhibitors"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Vasospasm", 
            "Sarpogrelate", 
            "Statin"
        ], 
        "lastchanged_date": "December 8, 2013", 
        "location": {
            "contact": {
                "email": "hcgwon@skku.edu", 
                "last_name": "Hyoen-Cheol Gwon, MD,PhD", 
                "phone": "82-2-3410-3418"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "135-710"
                }, 
                "name": "Hyoen-Cheol Gwon, MD,PhD"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Single-center, Randomized Study to Evaluate the Effect of Sarpogrelate, a Selective Serotonin Receptor Antagonist, and High Dose Statin on the Reduction of Coronary Spasm in the Patients With Variant Angina", 
        "overall_contact": {
            "email": "hcgwon@skku.edu", 
            "last_name": "Hyeon-Cheol Gwon, MD,PhD", 
            "phone": "82-2-3410-3419"
        }, 
        "overall_contact_backup": {
            "email": "jhysmc@gmail.com", 
            "last_name": "Jeong Hoon Yang, MD", 
            "phone": "82-2-3410-3419"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Ergonovine provocation test 12months later", 
            "safety_issue": "No", 
            "time_frame": "1 year later"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01674686"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Samsung Medical Center", 
            "investigator_full_name": "Hyeon-Cheol Gwon", 
            "investigator_title": "professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "C-reactive protein lever 12months later", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "Samsung Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Samsung Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}